Clinical Trials Directory

Trials / Completed

CompletedNCT05153473

Assessment of the Safety and the Performance of the SAGITTA EVL R Stems in Hip Arthroplasties

Retro-prospective and Observational Study of 120 Patients for the Assessment of the Safety and the Performance of the SAGITTA EVL R Stems in Hip Arthroplasties

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
Societe dEtude, de Recherche et de Fabrication · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Total hip arthroplasty is the preferred treatment for hip disease (primary or secondary osteoarthritis, osteonecrosis, for example) and femoral neck fractures. Revision risk factors reported when considering the main surgical approaches. Studied from the Dutch arthroplasty registry found a revision rate in hemiarthroplasty (HA) of 1.6% at 1 year and 2.5% at 5 years postoperatively. For total hip replacement (THA), the rate was 2.4% at 1 and 4.3% at 5 years postoperatively. Analyze shows that the risk factors for hemiarthroplasty were male sex, age under 80 (regardless of gender), posterolateral approach and uncemented fixation. The risk factors for HAT were exactly the same, but they found that smoking also played a role. It should be noted that age as a risk factor for revision is not a risk during the first year after the fracture, but becomes one in the years that follow. In order to maintain compliance with the directive on medical devices (93/42 / EEC \[M5\]) and the future regulation (EU) (2017/745) relating to medical devices, SERF has set up post-market clinical follow-ups ( PMCF). This PMCF study aims to improve knowledge related to the performance, safety and benefit / risk ratio of the Sagitta EVL-R stem and to monitor patient care strategy through this clinical evaluation. Significant clinical results as well as safety must be confirmed with this patient cohort. It is important to note that this cohort reflects the specific care strategy of the University Hospital of Poitiers. Therefore, the strategy could be different between hospitals and countries.

Conditions

Interventions

TypeNameDescription
DEVICETotal Hip Arthroplasty RevisionHip revision surgery is performed to repair an artificial hip joint (prosthesis) that has been damaged over time due to an infection, or due to normal wear and tear of the prosthetic hip. Revision surgery helps to correct the problem so the hip can function normally again.

Timeline

Start date
2019-06-24
Primary completion
2019-06-26
Completion
2019-11-08
First posted
2021-12-10
Last updated
2024-11-29
Results posted
2024-11-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05153473. Inclusion in this directory is not an endorsement.

Assessment of the Safety and the Performance of the SAGITTA EVL R Stems in Hip Arthroplasties (NCT05153473) · Clinical Trials Directory